Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 4, Issue 4, Pages 225-231
http://dx.doi.org/10.1155/S1064744996000439

Investigations by Cell-Mediated Immunologic Tests and Therapeutic Trials With Thymopentin in Vaginal Mycoses

1Department of Gynecology and Obstetrics, Wuppental St. Antonius Hospital, Düsseldorf Heinrich Heine Uiversität, Düsseldorf, Germany
2Department of Gynecology and Obstetrics, Düsseldorf Heinrich Heine Uiversität, Düsseldorf, Germany
3Klinik für Frauenheilkunde und Geburtshilfe, Klinikum Frankfurt (Oder), Müllroser Chaussee 7, Frankfurt (Oder) Markendorf D-15236, Germany

Received 15 March 1996; Accepted 23 July 1996

Copyright © 1996 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [25 citations]

The following is the list of published articles that have cited the current article.

  • Steele, Ozenci, Luo, Scott, and Paul L. Fidel Jr., “Growth inhibition of Candida albicans by vaginal cells from naive mice,” Medical Mycology, vol. 37, no. 4, pp. 251–259, 1999. View at Publisher · View at Google Scholar
  • J Chaiban, Pl Fidel, and Fl Wormley, “Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis,” Infection And Immunity, vol. 69, no. 8, pp. 5072–5079, 2001. View at Publisher · View at Google Scholar
  • Rk Swoboda, Na Wolf, Jd Sobel, Je Leigh, T Myers, J Thompson, M Barousse, Pl Fidel, Jl Cutright, and S Hager, “Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis,” Journal Of Infectious Diseases, vol. 183, no. 2, pp. 277–285, 2001. View at Publisher · View at Google Scholar
  • Paul L. Fidel Jr., “The protective immune response against vaginal candidiasis: Lessons learned from clinical studies and animal models,” International Reviews of Immunology, vol. 21, no. 6, pp. 515–548, 2002. View at Publisher · View at Google Scholar
  • C Seebacher, and W Mendling, “Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics,” Mycoses, vol. 46, no. 9-10, pp. 365–369, 2003. View at Publisher · View at Google Scholar
  • P. L. Fidel, M. Barousse, V. Lounev, T. Espinosa, R. R. Chesson, and K. Dunlap, “ Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle ,” Medical Mycology, vol. 41, no. 2, pp. 97–109, 2003. View at Publisher · View at Google Scholar
  • Pl Fidel, “History and new insights into host defense against vaginal candidiasis,” Trends In Microbiology, vol. 12, no. 5, pp. 220–227, 2004. View at Publisher · View at Google Scholar
  • Mendling, and Seebacher, “Guideline for vulvovaginal candidosis,” JDDG - Journal of the German Society of Dermatology, vol. 2, no. 2, pp. 149–152, 2004. View at Publisher · View at Google Scholar
  • V Buchta, and J Spacek, “Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: comparison of a 1-day and a 3-day regimen,” Mycoses, vol. 48, no. 3, pp. 165–171, 2005. View at Publisher · View at Google Scholar
  • M Hronek, V Buchta, M Forstl, J Spacek, M Holeckova, and P Jilek, “The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls,” Mycoses, vol. 48, no. 6, pp. 391–395, 2005. View at Publisher · View at Google Scholar
  • H Meyer, S Goettlicher, and W Mendling, “Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy,” Mycoses, vol. 49, no. 3, pp. 202–209, 2006. View at Publisher · View at Google Scholar
  • Paul L. Fidel, “History and update on host defense against vaginal candidiasis,” American Journal Of Reproductive Immunology, vol. 57, no. 1, pp. 2–12, 2007. View at Publisher · View at Google Scholar
  • Gilbert G.G. Donders, Gert Bellen, and Werner Mendling, “Management of recurrent vulvo-vaginal candidosis as a chronic illness,” Gynecologic and Obstetric Investigation, vol. 70, no. 4, pp. 306–321, 2010. View at Publisher · View at Google Scholar
  • W. Mendling, and V. Birkner, “Vaccination with Inactivated Lactobacilli or Heliotherapy Can Improve the Quality-of-Life of Women with Chronic Recurrent Vulvovaginal Candidosis - a Prospective Randomized Study,” Geburtshilfe Und Frauenheilkunde, vol. 71, no. 9, pp. 767–772, 2011. View at Publisher · View at Google Scholar
  • Paul L. Fidel Jr., and Jim E. Cutler, “Prospects for development of a vaccine to prevent and control vaginal candidiasis,” Current Infectious Disease Reports, vol. 13, no. 1, pp. 102–107, 2011. View at Publisher · View at Google Scholar
  • Junko Yano, Mairi C. Noverr, and Paul L. Fidel, “Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins,” Cytokine, vol. 58, no. 1, pp. 118–128, 2012. View at Publisher · View at Google Scholar
  • W. Mendling, and J. Brasch, “Guideline vulvovaginal candidosis (2010) of the german society for gynecology and obstetrics, the working group for infections and infectimmunology in gynecology and obstetrics, the german society of dermatology, the board of german dermatologists and the,” Mycoses, vol. 55, pp. 1–13, 2012. View at Publisher · View at Google Scholar
  • Yang Wang, Yan Cao, Yiming Meng, Zhenyu You, Xiaowei Liu, and Zhihong Liu, “The novel role of thymopentin in induction of maturation of bone marrow dendritic cells (BMDCs),” International Immunopharmacology, vol. 21, no. 2, pp. 255–260, 2014. View at Publisher · View at Google Scholar
  • Brian M. Peters, Junko Yano, Mairi C. Noverr, and Paul L. Fidel Jr., “Candida Vaginitis: When Opportunism Knocks, the Host Responds,” PLoS Pathogens, vol. 10, no. 4, 2014. View at Publisher · View at Google Scholar
  • W. Mendling, K. Friese, I. Mylonas, E. -R. Weissenbacher, J. Brasch, M. Schaller, P. Mayser, I. Effendy, G. Ginter-Hanselmayer, H. Hof, O. Cornely, and M. Ruhnke, “Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. ,” Geburtshilfe Und Frauenheilkunde, vol. 75, no. 4, pp. 342–354, 2015. View at Publisher · View at Google Scholar
  • Vincent M. Bruno, Amol C. Shetty, Junko Yano, Paul L. Fidel, Mairi C. Noverr, and Brian M. Peters, “Transcriptomic Analysis of Vulvovaginal Candidiasis Identifies a Role for the NLRP3 Inflammasome,” Mbio, vol. 6, no. 2, 2015. View at Publisher · View at Google Scholar
  • Werner Mendling, “Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis),” Mycoses, vol. 58, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • Yuanyan Tan, Wei Wang, Chunlei Wu, Zhengyin Pan, Guiyang Yao, Lijing Fang, and Wu Su, “Myristic acid-modified thymopentin for enhanced plasma stability and immune-modulating activity,” International Immunopharmacology, vol. 47, pp. 88–94, 2017. View at Publisher · View at Google Scholar
  • Junko Yano, Mairi C. Noverr, and Paul L. Fidel, “Vaginal heparan sulfate linked to neutrophil dysfunction in the acute inflammatory response associated with experimental vulvovaginal candidiasis,” mBio, vol. 8, no. 2, 2017. View at Publisher · View at Google Scholar
  • Mairi C. Noverr, Junko Yano, Brian M. Peters, and Paul L. Fidel, “Novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: "neutrophil anergy",” Infection and Immunity, vol. 86, no. 3, 2018. View at Publisher · View at Google Scholar